CK2.3
BMP receptor II-derived CK2.3 peptide
20 Amino Acids · MW: NA
Amino Acids
20
Molecular Weight
NA
Half-life
unknown
Research Score
4.2
Studies
85
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is CK2.3?
CK2.3 is a synthetic peptide derived from the BMP receptor signaling region and studied as an anabolic bone and joint-tissue modulator. Preclinical work suggests it can promote bone formation and may help preserve cartilage in osteoarthritis models.
Key Benefits & Mechanisms
bone anabolic
cartilage-preserving
osteochondral repair support
Research Summary
Animal studies indicate CK2.3 can influence BMP-related signaling, increasing bone formation while showing cartilage-protective effects in degenerative joint models. It remains investigational and has no approved clinical use for arthritis.
Related Peptides
Abaloparatide
Parathyroid hormone-related protein (PTHrP) analog
Abaloparatide is a synthetic 34-amino-acid analog derived from PTHrP signaling biology. It preferentially activates the PTH1 receptor in a way that supports bone formation with less calcium burden than some older agents.
Bone & JointParathyroid hormone (1-84)
Human parathyroid hormone full-length peptide
Parathyroid hormone (1-84) is the full-length native human PTH molecule. Intermittent exposure can drive bone remodeling toward bone formation, and it remains clinically relevant in calcium-bone disorders.
Bone & JointParathyroid hormone-related protein (1-36)
N-terminal PTHrP fragment
Parathyroid hormone-related protein (1-36) is an N-terminal fragment that activates the same receptor family as PTH. It has been studied as a potential bone-anabolic peptide in preclinical osteoporosis and osteoblast models.
Bone & Joint